ELOVL6 and type 2 diabetes mellitus: Our results have potential clinical implications, especially related to the vascular complications in type 2 diabetes and obese subjects because previous studies showed that Elovl6 expression is transcriptionally induced by insulin and overnutrition through the action of the lipogenic transcription factor, SREBP1c9, 53 in hepatocytes.